IMAG±iNe 2.0 study: How biomarkers could help researchers better understand IgM-associated PN
Interview with Perry van Doormaal, MD, PhD
In this interview, Amanda Homscheid, FPN Program Manager, speaks with Perry van Doormaal, MD, PhD, a Senior Researcher at the University Medical Center Utrecht in the Netherlands and Principal Investigator of the IMAG±iNe study. This study focuses on a rare nerve disease called IgM-associated peripheral neuropathy, which can happen with or without something called anti-MAG antibodies.
In this interview, Dr. van Doormaal talks about a new study that builds on what researchers learned from the original IMAG±iNe study. This next step, often called IMAG±iNe 2.0, uses biomarkers to better understand the disease. He explains what this new study hopes to learn, how it will work, and how it may help improve care for people living with IgM-related peripheral neuropathy.
Watch the interview with Dr. van Doormaal to learn more.
For more information, read our blog post: A powerful new study to predict and improve care for anti-MAG neuropathy.
The IMAG±iNe 2.0 study is funded by the Foundation for Peripheral Neuropathy, with support from our donors- thank you! If you’d like to support this research, visit https://www.foundationforpn.org/donate/ or reach out to us at [email protected].
